XNYSAMWL
Market cap131mUSD
Jan 16, Last price
9.60USD
1D
13.88%
1Q
-7.16%
IPO
-58.30%
Name
American Well Corp
Chart & Performance
P/E
—
P/S
0.51
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
47.59%
Rev. gr., 5y
17.85%
Revenues
259m
-6.55%
Net income
-675m
L+150.25%
CFO
-148m
L-22.87%
Earnings
Feb 12, 2025
Profile
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 259,047 -6.55% | 277,190 9.65% | ||||
Cost of revenue | 483,219 | 526,890 | ||||
Unusual Expense (Income) | ||||||
NOPBT | (224,172) | (249,700) | ||||
NOPBT Margin | ||||||
Operating Taxes | 3,860 | 64 | ||||
Tax Rate | ||||||
NOPAT | (228,032) | (249,764) | ||||
Net income | (675,164) 150.25% | (269,794) 55.37% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | (586) | 5,380 | ||||
BB yield | 2.77% | -13.86% | ||||
| Debt | ||||||
Debt current | 7,160 | 3,057 | ||||
Long-term debt | 19,992 | 26,631 | ||||
Deferred revenue | 6,091 | 6,289 | ||||
Other long-term liabilities | 1,425 | 1,574 | ||||
Net debt | (346,066) | (509,653) | ||||
| Cash flow | ||||||
Cash from operating activities | (148,343) | (192,323) | ||||
CAPEX | (292) | (10,447) | ||||
Cash from investing activities | (19,168) | (11,630) | ||||
Cash from financing activities | 2,147 | (3,612) | ||||
FCF | (224,536) | (245,628) | ||||
| Balance | ||||||
Cash | 372,038 | 538,546 | ||||
Long term investments | 1,180 | 795 | ||||
Excess cash | 360,266 | 525,482 | ||||
Stockholders' equity | (1,754,582) | (1,076,257) | ||||
Invested Capital | 2,257,650 | 2,182,815 | ||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 14,213 | 13,712 | ||||
Price | 1.49 -47.35% | 2.83 -53.15% | ||||
Market cap | 21,177 -45.43% | 38,806 -49.42% | ||||
EV | (308,922) | (450,873) | ||||
EBITDA | (192,248) | (223,533) | ||||
EV/EBITDA | 1.61 | 2.02 | ||||
Interest | 6,123 | |||||
Interest/NOPBT | ||||||